RYHTY OTC
Ryman Healthcare Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -26.5%
1Y: -14.1%
3Y: -67.1%
5Y: -88.1%
$6.11
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$824M
+15.5% ▲
5Y CAGR: +12.7%
Gross Profit
-$18M
-102.6% ▼
Operating Income
-$18M
+84.5% ▲
Net Income
-$177M
+59.5% ▲
EPS (Diluted)
$-0.90
+70.5% ▲
EBITDA
$26M
+194.3% ▲
5Y CAGR: -43.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $504M | $560M | $651M | $714M | $824M |
| YoY Growth | +11.3% | +11.2% | +16.1% | +9.7% | +15.5% |
| Cost of Revenue | $502M | $580M | $652M | $0 | $843M |
| Gross Profit | $2M | -$20M | -$1M | $714M | -$18M |
| Gross Margin | 0.4% | -3.5% | -0.2% | 100.0% | -2.2% |
| R&D Expenses | $5M | $12M | $16M | $0 | $0 |
| SG&A Expenses | $306M | $177M | $464M | $544M | $0 |
| Operating Expenses | $710M | $216M | $720M | $832M | $0 |
| Operating Income | $2M | -$20M | -$70M | -$118M | -$18M |
| Operating Margin | 0.4% | -3.5% | -10.7% | -16.6% | -2.2% |
| Interest Expense | $31M | $120M | $50M | $140M | $123M |
| Income Before Tax | $722M | $206M | -$145M | -$215M | -$183M |
| Tax Expense | $29M | -$52M | -$150M | $221M | -$6M |
| Net Income | $693M | $258M | $5M | -$437M | -$177M |
| Net Margin | 137.5% | 46.0% | 0.7% | -61.2% | -21.5% |
| EPS (Diluted) | $6.55 | $2.50 | $0.03 | $-3.05 | $-0.90 |
| EBITDA | $788M | $458M | -$51M | -$27M | $26M |
| Shares Outstanding | 106M | 103M | 138M | 142M | 203M |